With experimental treatments in short supply, some researchers think existing medicines might work. (science.sciencemag.org)
The study is the latest work from The George Institute questioning the effectiveness of existing medicines for treating back pain. (sciencedaily.com)
«This therapeutic approach offers new hope for people whose migraines can not be treated with existing medicine,» says Stephen D. Silberstein, M.D., principal investigator of the HALO CM trial, Professor of Neurology and Director of the Jefferson Headache Center at the Jack & Vicki Farber Institute for Neuroscience at Thomas Jefferson University Hospital. (sciencedaily.com)